|
?:authorAffiliation
|
-
[\'Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.\', \'McMaster Centre for Transfusion Research, Hamilton, ON, Canada.\', \'Department of Thrombosis and Haemostasis, Giessen University Hospital, Giessen, Germany.\', \'Cardeza Foundation for Hematological Research, Thomas Jefferson University, Philadelphia, PA, USA.\', \'Haematology Department, The Canberra Hospital, Canberra, ACT, Australia.\', \'John Curtin School of Medical Research, ANU, Canberra, ACT, Australia.\', \'Transfusion Medicine, Medical Faculty of Tuebingen, University of Tuebingen, Tuebingen, Germany.\', \'Centre for Clinical Transfusion Medicine Tuebingen ZKT gGmbH, Tuebingen, Germany.\', \'Norwegian National Unit for Platelet Immunology, University Hospital of North Norway, Tromso, Norway.\', \'Versiti BloodCenter of Wisconsin Pediatric Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.\', \'Dana-Farber/Boston Children\'s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.\', \'Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tuebingen, University Hospital of Tuebingen, Tuebingen, Germany.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}